KELLI MARTIN: Open Payments
NPI 1558094748 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 33 payments from 13 companies in 2025. Trend: 2023 $270 · 2024 $287 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $213 |
| Janssen Biotech, Inc. | 4 | $96 |
| Exact Sciences Corporation | 3 | $53 |
| Ardelyx, Inc. | 2 | $49 |
| ABBVIE INC. | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Gilead Sciences, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| QOL Medical, LLC | 1 | $22 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, VOQUEZNA, The Cologuard Plus Collection Kit, MAVYRET, XELJANZ, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
